The coronavirus diseases 2019 (COVID-19) pneumonia with spontaneous pneumothorax: a case report

Xiaoxing Chen1, Guqin Zhang2, Yueting Tang3

  • 1Department of Geriatrics, Renmin Hospital of Wuhan University, Wuhan University, Wuhan, China.

BMC Infectious Diseases
|September 10, 2020
PubMed

Insights

This case study describes a COVID-19 patient who developed spontaneous pneumothorax late in recovery. Early CT diagnosis and thoracic drainage were crucial for managing this rare complication.

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • The global outbreak of coronavirus disease 2019 (COVID-19) has led to widespread pulmonary complications.
  • Spontaneous pneumothorax as a complication of COVID-19 pneumonia remains poorly understood.

Observation:

  • A 66-year-old male with COVID-19 pneumonia presented with fever, cough, and myalgia, initially responding to supportive and antiviral treatments.
  • On hospital day 30, the patient developed sudden chest pain and dyspnea, with CT revealing a significant left-sided pneumothorax.
  • Immediate thoracic closed drainage led to rapid improvement of respiratory distress.

Findings:

  • The patient recovered from COVID-19, with negative PCR tests, but later developed spontaneous pneumothorax.
  • Computed tomography (CT) imaging was essential for diagnosing the pneumothorax.
  • Thoracic closed drainage effectively treated the spontaneous pneumothorax.

Implications:

  • Clinicians should consider spontaneous pneumothorax in COVID-19 patients, particularly those with prolonged severe lung damage.
  • Prompt CT imaging and effective intervention are vital for managing pneumothorax in this patient population.
  • This case underscores the potential for delayed respiratory complications in severe COVID-19 cases.
Abstract

Related Concept Videos

Pneumothorax-I01:26

Pneumothorax-I

A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
887
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
694
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
672
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
578
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
2.2K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
856